- Home
- GRPN vs EVMN Comparison
GRPN vs EVMN Comparison
Compare GRPN & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRPN | EVMN |
|---|---|---|
| Founded | 2008 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 723.4M | 628.9M |
| IPO Year | 2011 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GRPN | EVMN |
|---|---|---|
| Price | $16.20 | $15.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $31.25 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 978.3K | 112.9K |
| Earning Date | 11-06-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $496,093,000.00 | $13,000,000.00 |
| Revenue This Year | $4.17 | N/A |
| Revenue Next Year | $10.63 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 160.00 |
| 52 Week Low | $9.21 | $15.78 |
| 52 Week High | $43.08 | $24.03 |
Technical Indicators
Market Signals| Indicator | GRPN | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 42.09 | N/A |
| Support Level | $15.50 | N/A |
| Resistance Level | $17.46 | N/A |
| Average True Range (ATR) | 0.84 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 22.49 | 0.00 |
Price Performance
Historical ComparisonAbout GRPN Groupon Inc.
Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.